Annemarie Hanekamp has overseen some of the most transformative changes in oncology over her years in Big Pharma. Now, she ...
RNA is a long, polymeric molecule, composed of four different building blocks called nucleotides. In the last decade mRNA has progressed into a promising new class of medicine, with the potential to ...
- Mitglied im PLT (Philips Leadership Team) & OLT (Operations Leadership Team) - Leiter der Industrial Strategy & Sourcing Boards, OpEx, Industrial Engineering, Technologie - Mitglied Strategie- & ...
Furthermore, a need for manufacturing reliability in an increasingly uncertain geopolitical environment is pushing more companies to examine manufacturing closer to home. Unfortunately ...
Mainz – Der Impfstoffhersteller Biontech hat in den USA im Streit um Lizenzgebühren millionenschwere Vergleiche geschlossen. Insgesamt umgerechnet 1,2 Milliarden Euro wird das Unternehmen aus ...
In 2024, China's industrial landscape has witnessed a series of exciting "firsts" and groundbreaking achievements which reflect the robust momentum of China's manufacturing sector and underscore ...
German pharmaceutical company BioNTech has agreed to pay a combined sum of more than $1.2 billion to resolve separate disputes over royalty payments related to its COVID-19 vaccine. https://p.dw ...
BioNTech has agreed to pay $1.26 billion across two separate settlements with the National Institutes of Health and the University of Pennsylvania tied to royalties for its Covid-19 vaccine. The ...
(RTTNews) - BioNTech SE (BNTX), Friday reached two separate settlements with the U.S. National Institutes of Health, and the University of Pennsylvania regarding the royalties payment of COVID-19 ...
BioNTech has entered into settlement agreements with the NIH and the University of Pennsylvania, marking a key turning point in the long-running disputes and the … ...
BioNTech (NASDAQ:BNTX) announced Friday two separate agreements worth more than $1B with the National Institutes of Health (NIH) and the University of Pennsylvania to resolve royalty and other ...
(Reuters) -BioNTech has entered into two separate settlement agreements with the U.S. National Institutes of Health and the University of Pennsylvania over the payment of royalties related to its ...